Document Detail

Nuclear reprogramming and its role in vascular smooth muscle cells.
MedLine Citation:
PMID:  23881547     Owner:  NLM     Status:  In-Data-Review    
In general terms, "nuclear reprogramming" refers to a change in gene expression profile that results in a significant switch in cellular phenotype. Nuclear reprogramming was first addressed by pioneering studies of cell differentiation during embryonic development. In recent years, nuclear reprogramming has been studied in great detail in the context of experimentally controlled dedifferentiation and transdifferentiation of mammalian cells for therapeutic purposes. In this review, we present a perspective on nuclear reprogramming in the context of spontaneous, pathophysiological phenotypic switch of vascular cells occurring in the atherosclerotic lesion. In particular, we focus on the current knowledge of epigenetic mechanisms participating in the extraordinary flexibility of the gene expression profile of vascular smooth muscle cells and other cell types participating in atherogenesis. Understanding how epigenetic changes participate in vascular cell plasticity may lead to effective therapies based on the remodelling of the vascular architecture.
Silvio Zaina; Maria Del Pilar Valencia-Morales; Fabiola E Tristán-Flores; Gertrud Lund
Related Documents :
24921657 - An increase in reactive oxygen species by deregulation of arnt enhances chemotherapeuti...
23225767 - Biological evaluation of intervertebral disc cells in different formulations of gellan ...
24604387 - Klf8 knockdown suppresses proliferation and invasion in human osteosarcoma cells.
23606687 - Cytotoxicity induced by docetaxel in human oral squamous cell carcinoma cell lines.
1922787 - Regulation of neurotensin content in adrenal medullary cells: comparison of pc12 cells ...
16349497 - Significance of viral lysis and flagellate grazing as factors controlling bacterioplank...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Current atherosclerosis reports     Volume:  15     ISSN:  1534-6242     ISO Abbreviation:  Curr Atheroscler Rep     Publication Date:  2013 Sep 
Date Detail:
Created Date:  2013-07-24     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100897685     Medline TA:  Curr Atheroscler Rep     Country:  United States    
Other Details:
Languages:  eng     Pagination:  352     Citation Subset:  IM    
Department of Medical Sciences, Division of Health Sciences, León Campus, University of Guanajuato, 20 de Enero no. 929, 37320, León, Gto., Mexico,
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Hypoglycemia as a driver of cardiovascular risk in diabetes.
Next Document:  Calibration of self-reported dietary measures using biomarkers: an approach to enhancing nutritional...